Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector

McCandless, 2004, The burden of genetic disease on inpatient care in a children’s hospital, Am. J. Hum. Genet., 74, 121, 10.1086/381053

Friedmann, 1992, A brief history of gene therapy, Nat. Genet., 2, 93, 10.1038/ng1092-93

Misra, 2013, Human gene therapy: a brief overview of the genetic revolution, J. Assoc. Physicians India, 61, 127

Mingozzi, 2011, Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges, Nat. Rev. Genet., 12, 341, 10.1038/nrg2988

Gao, 2002, Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy, Proc. Natl. Acad. Sci. USA, 99, 11854, 10.1073/pnas.182412299

Zinn, 2014, Adeno-associated virus: fit to serve, Curr. Opin. Virol., 8, 90, 10.1016/j.coviro.2014.07.008

Naso, 2017, Adeno-associated virus (AAV) as a vector for gene therapy, BioDrugs, 31, 317, 10.1007/s40259-017-0234-5

Kaplitt, 2007, Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson’s disease: an open label, phase I trial, Lancet, 369, 2097, 10.1016/S0140-6736(07)60982-9

Vandendriessche, 2007, Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy, J. Thromb. Haemost., 5, 16, 10.1111/j.1538-7836.2006.02220.x

Zincarelli, 2008, Analysis of AAV serotypes 1–9 mediated gene expression and tropism in mice after systemic injection, Mol. Ther., 16, 1073, 10.1038/mt.2008.76

Wang, 2012, Hepatic gene transfer in neonatal mice by adeno-associated virus serotype 8 vector, Hum. Gene Ther., 23, 533, 10.1089/hum.2011.183

Jooss, 2003, Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy, Gene Ther., 10, 955, 10.1038/sj.gt.3302037

Boutin, 2010, Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors, Hum. Gene Ther., 21, 704, 10.1089/hum.2009.182

Calcedo, 2009, Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses, J. Infect. Dis., 199, 381, 10.1086/595830

Jenne, 2013, Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps, Cell Host Microbe, 13, 169, 10.1016/j.chom.2013.01.005

McDonald, 2017, Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice, Blood, 129, 1357, 10.1182/blood-2016-09-741298

van Golen, 2015, Platelet aggregation but not activation and degranulation during the acute post-ischemic reperfusion phase in livers with no underlying disease, J. Clin. Transl. Res., 1, 107

Clark, 2007, Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood, Nat. Med., 13, 463, 10.1038/nm1565

McDonald, 2012, Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis, Cell Host Microbe, 12, 324, 10.1016/j.chom.2012.06.011

Mingozzi, 2007, CD8+ T-cell responses to adeno-associated virus capsid in humans, Nat. Med., 13, 419, 10.1038/nm1549

Bessis, 2004, Immune responses to gene therapy vectors: influence on vector function and effector mechanisms, Gene Ther., 11, S10, 10.1038/sj.gt.3302364

Tang, 2006, Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins, Virology, 350, 312, 10.1016/j.virol.2006.01.024

Calcedo, 2018, Assessment of humoral, innate, and T-cell immune responses to adeno-associated virus vectors, Hum. Gene Ther. Methods, 29, 86, 10.1089/hgtb.2018.038

Van Rooijen, 1994, Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications, J. Immunol. Methods, 174, 83, 10.1016/0022-1759(94)90012-4

Lee, 2010, An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells, Nat. Immunol., 11, 295, 10.1038/ni.1855

Karimipoor, 2019, Study break: recent advances in hemophilia gene therapy, Iran. Biomed. J., 23, 7

Mahlangu, 2018, Updates in clinical trial data of extended half-life recombinant factor IX products for the treatment of haemophilia B, Ther. Adv. Hematol., 9, 335, 10.1177/2040620718802606

Borsotti, 2018, New technologies in gene therapy for inducing immune tolerance in hemophilia A, Expert Rev. Clin. Immunol., 14, 1013, 10.1080/1744666X.2018.1539667

Kubes, 2018, Immune responses in the liver, Annu. Rev. Immunol., 36, 247, 10.1146/annurev-immunol-051116-052415

Blaese, 1995, T lymphocyte-directed gene therapy for ADA− SCID: initial trial results after 4 years, Science, 270, 475, 10.1126/science.270.5235.475

Lukashev, 2016, Viral vectors for gene therapy: current state and clinical perspectives, Biochemistry (Mosc.), 81, 700, 10.1134/S0006297916070063

Tsai, 2000, Adenovirus-mediated transfer of regulable gene expression, Curr. Opin. Mol. Ther., 2, 515

Hacein-Bey-Abina, 2008, Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1, J. Clin. Invest., 118, 3132, 10.1172/JCI35700

Naldini, 1996, In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector, Science, 272, 263, 10.1126/science.272.5259.263

Montini, 2006, Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration, Nat. Biotechnol., 24, 687, 10.1038/nbt1216

Knolle, 2014, Hepatic immune regulation and its involvement in viral hepatitis infection, Gastroenterology, 146, 1193, 10.1053/j.gastro.2013.12.036

Grieger, 2016, Production of recombinant adeno-associated virus vectors using suspension HEK293 cells and continuous harvest of vector from the culture media for GMP FIX and FLT1 clinical vector, Mol. Ther., 24, 287, 10.1038/mt.2015.187

Jenne, 2011, The use of spinning-disk confocal microscopy for the intravital analysis of platelet dynamics in response to systemic and local inflammation, PLoS One, 6, e25109, 10.1371/journal.pone.0025109